Abbott Laboratories is a medical devices business based in the US. Abbott Laboratories shares (ABT) are listed on the NYSE and all prices are listed in US Dollars. Abbott Laboratories employs 115,000 staff and has a trailing 12-month revenue of around $40.2 billion.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $96.23 |
|---|---|
| 52-week range | $91.93 - $115.83 |
| 50-day moving average | $105.70 |
| 200-day moving average | $106.20 |
| Wall St. target price | $116.96 |
| PE ratio | 33.7645 |
| Dividend yield | $2 (2.03%) |
| Earnings per share (TTM) | $2.93 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $96.23 from 2023-09-26
| 1 week (2023-09-20) | -4.04% |
|---|---|
| 1 month (2023-08-25) | -7.66% |
| 3 months (2023-06-27) | -10.72% |
| 6 months (2023-03-27) | -2.26% |
| 1 year (2022-09-27) | -2.14% |
|---|---|
| 2 years (2021-09-24) | -22.63% |
| 3 years (2020-09-25) | 101.9289 |
| 5 years (2018-09-27) | 38.22% |
Valuing Abbott Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Abbott Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $40.2 billion |
|---|---|
| Operating margin TTM | 16.62% |
| Gross profit TTM | $24.6 billion |
| Return on assets TTM | 5.66% |
| Return on equity TTM | 13.93% |
| Profit margin | 12.83% |
| Book value | $21.42 |
| Market Capitalization | $171.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 46.62% of net profits
Recently Abbott Laboratories has paid out, on average, around 46.62% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.03% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Abbott Laboratories shareholders could enjoy a 2.03% return on their shares, in the form of dividend payments. In Abbott Laboratories's case, that would currently equate to about $2 per share.
While Abbott Laboratories's payout ratio might seem fairly standard, it's worth remembering that Abbott Laboratories may be investing much of the rest of its net profits in future growth.
Abbott Laboratories's most recent dividend payout was on 14 August 2023. The latest dividend was paid out to all shareholders who bought their shares by 12 July 2023 (the "ex-dividend date").
Abbott Laboratories's shares were split on a 10000:4798 basis on 1 January 2013. So if you had owned 4798 shares the day before before the split, the next day you'd have owned 10000 shares. This wouldn't directly have changed the overall worth of your Abbott Laboratories shares – just the quantity. However, indirectly, the new 52% lower share price could have impacted the market appetite for Abbott Laboratories shares which in turn could have impacted Abbott Laboratories's share price.
Over the last 12 months, Abbott Laboratories's shares have ranged in value from as little as $91.9272 up to $115.83. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Abbott Laboratories's is 0.6732. This would suggest that Abbott Laboratories's shares are less volatile than average (for this exchange).
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Everything we know about the Discord IPO, plus information on how to buy in.
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.